The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Abstract
Purpose: To update a clinical practice guideline on the use of chemotherapy and radiation therapy protectants for patients with cancer. Methods: An update committee reviewed literature published since the last guideline update in 2002. Results: Thirty-nine reports met the inclusion criteria: palifermin and dexrazoxane, three reports (two studies) each; amifostine, 33 reports (31 studies); and mesna, no published randomized trials identified since 2002. Recommendations: Dexrazoxane is not recommended for routine use in breast cancer (BC) in adjuvant setting, or metastatic setting with initial doxorubicin-based chemotherapy. Consider use with metastatic BC and other malignancies, for patients who have received more than 300 mg/m 2 doxorubicin who may benefit from continued doxorubicin-containing therapy. Cardiac monitoring should continue in patients receiving doxorubicin. Amifostine may be considered for prevention of cisplatin-associated nephrotoxicity, reduction of grade 3 to 4 neutropenia (alternative strategies are reasonable), and to decrease acute and late xerostomia with fractionated radiation therapy alone for head and neck cancer. It is not recommended for protection against thrombocytopenia, prevention of platinum-associated neurotoxicity or ototoxicity or paclitaxel-associated neuropathy, prevention of radiation therapy–associated mucositis in head and neck cancer, or prevention of esophagitis during concurrent chemoradiotherapy for non–small-cell lung cancer. Palifermin is recommended to decrease severe mucositis in autologous stem-cell transplantation (SCT) for hematologic malignancies with total-body irradiation (TBI) conditioning regimens, and considered for patients undergoing myeloablative allogeneic SCT with TBI-based conditioning regimens. Data are insufficient to recommend use in the non-SCT setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
Sonis, S. T., Elting, L. S., Keefe, D., Peterson, D. E., Schubert, M., Hauer-Jensen, M., Bekele, B. N., Raber-Durlacher, J., Donnelly, J. P., Rubenstein, E. B., et al. (2004) · Cancer · doi:10.1002/cncr.20162 · Cited by 1,417
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040125 · Cited by 893
Self-citationPurification and characterization of a newly identified growth factor specific for epithelial cells.
Rubin, J. S., Osada, H., Finch, P. W., Taylor, W. G., Rudikoff, S., & Aaronson, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.802 · Cited by 833
Trotti, A., Byhardt, R., Stetz, J., Gwede, C., Corn, B., Fu, K., Gunderson, L., McCormick, B., Morris∫, M., Rich, T., et al. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00559-3 · Cited by 804
Self-citationOral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
Sonis, S. T., Oster, G., Fuchs, H., Bellm, L., Bradford, W. Z., Edelsberg, J., Hayden, V., Eilers, J., Epstein, J. B., LeVeque, F. G., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2201 · Cited by 678
Interventions for treating oral mucositis for patients with cancer receiving treatment
Clarkson, J. E., Worthington, H. V., Furness, S., McCabe, M., Khalid, T., & Meyer, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001973.pub4 · Cited by 674
Tebbi, C. K., London, W. B., Friedman, D., Villaluna, D., De Alarcon, P. A., Constine, L. S., Mendenhall, N. P., Sposto, R., Chauvenet, A., & Schwartz, C. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.3879 · Cited by 493
Sonis, S. T., Eilers, J. P., Epstein, J. B., LeVeque, F. G., Liggett, W. H., Mulagha, M. T., Peterson, D. E., Rose, A. H., Schubert, M. M., Spijkervet, F. K., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990515)85:10<2103::aid-cncr2>3.0.co;2-0 · Cited by 403
Patient reports of complications of bone marrow transplantation
Bellm, L. A., Epstein, J. B., Rose-Ped, A., Martin, P., & Fuchs, H. J. (2000) · Supportive Care in Cancer · doi:10.1007/s005209900095 · Cited by 366
Farrell, C. L., Bready, J. V., Rex, K. L., Chen, J. N., DiPalma, C., Whitcomb, K. L., Yin, S., Hill, D. C., Wiemann, B., Starnes, C. O., et al. (1998) · PubMed · Cited by 357
Interventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub4 · Cited by 298
Movsas, B., Scott, C., Langer, C., Werner-Wasik, M., Nicolaou, N., Komaki, R., Machtay, M., Smith, C., Axelrod, R., Sarna, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.167 · Cited by 225
Self-citationSerious adverse effects of amifostine during radiotherapy in head and neck cancer patients
Rades, D., Fehlauer, F., Bajrovic, A., Mahlmann, B., Richter, E., & Alberti, W. (2004) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2003.10.005 · Cited by 213
Antonadou, D., Coliarakis, N., Synodinou, M., Athanassiou, H., Kouveli, A., Verigos, C., Georgakopoulos, G., Panoussaki, K., Karageorgis, P., & Throuvalas, N. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01713-8 · Cited by 201
Sasse, A. D., de Oliveira Clark, L. G., Sasse, E. C., & Clark, O. A. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.06.023 · Cited by 198
Komaki, R., Lee, J. S., Milas, L., Lee, H. K., Fossella, F. V., Herbst, R. S., Allen, P. K., Liao, Z., Stevens, C. W., Lu, C., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.10.005 · Cited by 172
Wasserman, T. H., Brizel, D. M., Henke, M., Monnier, A., Eschwege, F., Sauer, R., & Strnad, V. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.966 · Cited by 170
Self-citationBlazar, B. R., Weisdorf, D. J., DeFor, T. E., Goldman, A. I., Braun, T., Silver, S., & Ferrara, J. L. M. (2006) · Blood · doi:10.1182/blood-2006-04-017780 · Cited by 152
Meropol, N. J., Somer, R. A., Gutheil, J. C., Pelley, R. J., Modiano, M., Rowinsky, E. K., Rothenberg, M. L., Redding, S. W., Serdar, C. M., Yao, B., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.079 · Cited by 148
Self-citationStiff, P. J., Emmanouilides, C. E., Bensinger, W., Gentile, T., Blazar, B. R., Shea, T. C., Lu, J., Isitt, J. J., Cesano, A., & Spielberger, R. T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8340 · Cited by 147
Bernstein, M. L., Devidas, M., Lafreniere, D., Souid, A.-K., Meyers, P. A., Gebhardt, M. C., Stine, K. C., Nicholas, R. W., Perlman, E. J., Dubowy, R. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.1717 · Cited by 135
Interventions for preventing oral mucositis for patients with cancer receiving treatment
Worthington, H. V., Clarkson, J., & Eden, O. B. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000978.pub2 · Cited by 130
Rosen, L. S., Abdi, E. A., Davis, I. D., Gutheil, J. C., Schnell, F. M., Zalcberg, J. R., Cesano, A., Gayko, U., Chen, M.-G., & Clarke, S. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1152 · Cited by 110
FARRELL, K. L. R. C. L. (1999) · International Journal of Radiation Biology · doi:10.1080/095530099140258 · Cited by 103
Antonadou, D., Throuvalas, N., Petridis, A., Bolanos, N., Sagriotis, A., & Synodinou, M. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00590-x · Cited by 97
Hilpert, F., Stähle, A., Tomé, O., et al. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0782-y · Cited by 70
Spencer, A. G., Horvath, N., Gibson, J., Prince, H. M., Herrmann, R., Bashford, J., Joske, D. J. L., Grigg, A., McKendrick, J., Prosser, I. W., et al. (2005) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1704946 · Cited by 68
Interventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub2 · Cited by 54
Beaven, A., & Shea, T. C. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.16.2287 · Cited by 22
Cited by
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,544
Zamorano, J. L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,795
Mechanisms of Cisplatin Nephrotoxicity
Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,622
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,414
Metadata
- Authors
- Hensley, M. L., Hagerty, K. L., Kewalramani, T., Green, D. M., Meropol, N. J., Wasserman, T. H., Cohen, G. I., Emami, B., Gradishar, W. J., Mitchell, R. B., Thigpen, J. T., Trotti, A., von Hoff, D., & Schuchter, L. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-01-01
- Volume
- 27
- Issue
- 1
- Pages
- 127-145
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2127785542
- Cited by
- 540
- References
- 30
- FWCI
- 22.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.